Balansag, Angelica U.

HRN: 17-26-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2025
AMPICILLIN 1GM (VIAL)
08/27/2025
08/29/2025
IV
2 G
Every 6 Hours
Leaking BOW
Checking Initial Appropriateness 
08/28/2025
CEFUROXIME 1.5GM (VIAL)
08/28/2025
08/29/2025
IVTT
1.5g
Q8h
SP LTCS
Checking Initial Appropriateness 
08/29/2025
CEFUROXIME 500MG (TAB)
08/29/2025
09/05/2025
ORAL
500mg
BID
S/P CS
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: